Probity Advisors, Inc. Sanofi Transaction History

Probity Advisors, Inc.

$480 Million
Q1 2024

A detailed history of Probity Advisors, Inc. transactions in Sanofi stock. As of the latest transaction made, Probity Advisors, Inc. holds 11,319 shares of SNY stock, worth $553,046. This represents 0.11% of its overall portfolio holdings.

Number of Shares

11,319

Previous 10,781 4.99%

Holding current value

$553,046

Previous $536,000 2.61%

% of portfolio

0.11%

Previous 0.12%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$45.75 - $52.48 $24,613 - $28,234	538 Added 4.99%	11,319 $550,000
Q4 2023 Feb 12, 2024	BUY	$43.13 - $54.79 $55,077 - $69,966	1,277 Added 13.44%	10,781 $536,000
Q3 2023 Nov 14, 2023	BUY	$50.95 - $55.2 $1,579 - $1,711	31 Added 0.33%	9,504 $509,000
Q2 2023 Aug 10, 2023	BUY	$50.45 - $57.18 $26,385 - $29,905	523 Added 5.84%	9,473 $510,000
Q4 2022 Feb 14, 2023	SELL	$38.86 - $48.55 $8,704 - $10,875	-224 Reduced 2.44%	8,950 $433,000

Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $36,996 - $99,897	-994 Reduced 9.78%	9,174 $349,000
Q2 2022 Aug 12, 2022	BUY	$48.99 - $57.46 $20,575 - $24,133	420 Added 4.31%	10,168 $509,000
Q1 2022 May 10, 2022	SELL	$48.48 - $53.65 $36,893 - $40,827	-761 Reduced 7.24%	9,748 $500,000
Q4 2021 Feb 10, 2022	BUY	$47.07 - $52.35 $60,532 - $67,322	1,286 Added 13.94%	10,509 $527,000
Q3 2021 Oct 08, 2021	BUY	$47.89 - $53.12 $108,758 - $120,635	2,271 Added 32.67%	9,223 $445,000
Q2 2021 Aug 06, 2021	BUY	$49.36 - $54.25 $22,606 - $24,846	458 Added 7.05%	6,952 $366,000
Q1 2021 Apr 28, 2021	BUY	$45.46 - $50.51 $295,217 - $328,011	6,494 New	6,494 $321,000

Others Institutions Holding SNY

# of Institutions

756

Shares Held

236M

Call Options Held

1.27M

Put Options Held

1.57M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.

Account

Probity Advisors, Inc. Sanofi Transaction History